Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease
- PMID: 39282945
- PMCID: PMC11884654
- DOI: 10.1093/brain/awae295
Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease
Abstract
Parkinson's disease (PD) is marked by the death of neuromelanin-rich dopaminergic and noradrenergic cells in the substantia nigra (SN) and the locus coeruleus (LC), respectively, resulting in motor and cognitive impairments. Although SN dopamine dysfunction has clear neurophysiological effects, the association of reduced LC norepinephrine signalling with brain activity in PD remains to be established. We used neuromelanin-sensitive T1-weighted MRI (PD, n = 58; healthy control, n = 27) and task-free magnetoencephalography (PD, n = 58; healthy control, n = 65) to identify neuropathophysiological factors related to the degeneration of the LC and SN in patients with PD. We found pathological increases in rhythmic alpha-band (8-12 Hz) activity in patients with decreased LC neuromelanin, which were more strongly associated in patients with worse attentional impairments. This negative alpha-band-LC neuromelanin relationship is strongest in fronto-motor cortices, where alpha-band activity is inversely related to attention scores. Using neurochemical co-localization analyses with normative atlases of neurotransmitter transporters, we also show that this effect is more pronounced in regions with high densities of norepinephrine transporters. These observations support a noradrenergic association between LC integrity and alpha-band activity. Our data also show that rhythmic beta-band (15-29 Hz) activity in the left somatomotor cortex decreases with lower levels of SN neuromelanin; the same regions where beta activity reflects axial motor symptoms. Together, our findings clarify the association of well-documented alterations of rhythmic neurophysiology in PD with cortical and subcortical neurochemical systems. Specifically, attention-related alpha-band activity is related to dysfunction of the noradrenergic system, and beta activity with relevance to motor impairments reflects dopaminergic dysfunction.
Keywords: Parkinson’s disease; cortical rhythms; locus coeruleus; magnetoencephalography; neuromelanin; substantia nigra.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.
Conflict of interest statement
The authors report no competing interests.
Figures



Update of
-
Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease.medRxiv [Preprint]. 2024 Feb 18:2024.02.16.24302958. doi: 10.1101/2024.02.16.24302958. medRxiv. 2024. Update in: Brain. 2025 Mar 06;148(3):875-885. doi: 10.1093/brain/awae295. PMID: 38405952 Free PMC article. Updated. Preprint.
Similar articles
-
Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease.medRxiv [Preprint]. 2024 Feb 18:2024.02.16.24302958. doi: 10.1101/2024.02.16.24302958. medRxiv. 2024. Update in: Brain. 2025 Mar 06;148(3):875-885. doi: 10.1093/brain/awae295. PMID: 38405952 Free PMC article. Updated. Preprint.
-
Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.Mov Disord. 2025 May;40(5):844-854. doi: 10.1002/mds.30148. Epub 2025 Feb 13. Mov Disord. 2025. PMID: 39945211 Free PMC article.
-
Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.Eur J Neurol. 2018 Jul;25(7):949-e73. doi: 10.1111/ene.13628. Epub 2018 Apr 11. Eur J Neurol. 2018. PMID: 29520900
-
Neuromelanin-sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease.Eur J Neurosci. 2024 May;59(10):2616-2627. doi: 10.1111/ejn.16296. Epub 2024 Mar 5. Eur J Neurosci. 2024. PMID: 38441250 Review.
-
Neuromelanin in parkinsonian disorders: an update.Int J Neurosci. 2017 Dec;127(12):1116-1123. doi: 10.1080/00207454.2017.1325883. Epub 2017 May 11. Int J Neurosci. 2017. PMID: 28460588 Review.
Cited by
-
Cortical Effects of Dopamine Replacement Account for Clinical Response Variability in Parkinson's Disease.Mov Disord. 2025 Apr 18:10.1002/mds.30200. doi: 10.1002/mds.30200. Online ahead of print. Mov Disord. 2025. PMID: 40249138
-
Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy.Cell Rep. 2025 Jan 28;44(1):115147. doi: 10.1016/j.celrep.2024.115147. Epub 2025 Jan 2. Cell Rep. 2025. PMID: 39752251 Free PMC article.
-
Cortical effects of dopamine replacement account for clinical response variability in Parkinson's disease.medRxiv [Preprint]. 2024 Nov 23:2024.11.20.24317429. doi: 10.1101/2024.11.20.24317429. medRxiv. 2024. Update in: Mov Disord. 2025 Apr 18. doi: 10.1002/mds.30200. PMID: 39606336 Free PMC article. Updated. Preprint.
-
Changes in sensorimotor network dynamics in resting-state recordings in Parkinson's disease.Brain Commun. 2025 Jul 23;7(4):fcaf282. doi: 10.1093/braincomms/fcaf282. eCollection 2025. Brain Commun. 2025. PMID: 40761478 Free PMC article.
References
-
- Jenkinson N, Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci. 2011;34:611–618. - PubMed
-
- Braak H, Del Tredici K, Rüb U, De Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211. - PubMed
-
- Del Tredici K, Braak H. Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson’s disease-related dementia. J Neurol Neurosurg Psychiatry. 2013;84:774–783. - PubMed
-
- Aston-Jones G, Rajkowski J, Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res. 2000;126:165–182. - PubMed
-
- Smith A, Nutt D. Noradrenaline and attention lapses. Nature. 1996;380(6572):291. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical